In conjunction with their recent public announcement, the Psychedelic Medicine Association would like to invite you to attend a free virtual event celebrating their official launch. As psychedelic medicine rapidly makes its way back into mainstream culture and medicine, the need to educate healthcare workers on the frontlines about this burgeoning field is crucial. Join Dr. Lynn Marie, founder and president of the Psychedelic Medicine Association, and our esteemed panel of experts as we take a deep dive into how the clinical education gap in psychedelic medicine can be bridged for better patient care.

Psychedelic Medicine Association speaker list

About the Psychedelic Medicine Association

 

The Psychedelic Medicine Association is a coalition of physicians, therapists, healthcare professionals and industry leaders dedicated to advancing education regarding the therapeutic uses of psychedelic medicines. Their expert team is eager to educate frontline healthcare professionals on the latest in psychedelic science so they have the tools they need to provide the best possible care to their patients. Here are the talented panelists that will be speaking at Tuesdays event:

 

 

Featured Panelists

 

Lynn Marie Morski, MD, ESQ – Dr. Morski is a Mayo Clinic-trained physician, attorney and adjunct law professor that also serves as the president and founding member of the Psychedelic Medicine Association. 

 

Alia Lilienstein, MD, MPH – Dr. Lilienstein is the medical director of the Multidisciplinary Association for Psychedelic Studies and the founder of the Illuminate Medicine Institute. 

 

Devon Christie, MD – Dr. Christie serves as the medical director for Numinus. 

 

Sean McAllister – Mr. McAllister is the executive officer of the Denver Psilocybin Mushroom Policy Review Panel.

psychedelic medicine association

Topics to be Explored at the Upcoming Event:

 

This expert panel discussion will focus on identifying the hurdles to incorporating psychedelics in the current medical models as well as presenting potential solutions.

The topics we explore include:

  • Education of primary care physicians on the basics of psychedelic medicines
  • Overcoming the stigma so clinicians feel comfortable discussing psychedelics with patients
  • Development of clinical practice guidelines
  • How clinicians can legally discuss currently illegal substances
  • How to get these medicines covered through health insurance

Microdose & The Conscious Fund Are Pleased to Support The Psychedelic Medicine Association

 

Microdose, in collaboration with The Conscious Fund, is excited to be a founding member of the Psychedelic Medicine Association and eager to support their novel efforts. As psychedelic therapies continue to become more mainstream, we encourage widespread efforts to educate both healthcare professionals and the general public about these novel medicines.

 

To read more about the Psychedelic Medicine Association and sign up for the live event, click here!